Skip to main content

Table 4 Effect of tamsulosin plus solifenacin on group B

From: The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

P-value After (mean ± SD) Before (mean ± SD)  
< 0.001 1.29 ± 0.498 4.37 ± 0.485 (1) Quality of life
< 0.001* 5.00 ± 1.064 11.43 ± 1.458 (2) OABSS
  1. Asterisk represents significant difference between both groups: P value < 0.05 was considered statistically significant